The present invention relates to a retractable tip for a vitrectomy tool, and more particularly to a retractable sharpened tip for use in vitreous cutter probes to provide a sharp tip necessary to insert the probe into the vitreous cavity and, when retracted provides safe operation.
It is common practice to extract small amounts of vitreous material from a person's eye in order to provide a sample of the material for examination or in order to remove material so that antibiotics or other drugs may be injected into the eye. Typically, any injection into the eye can result in excess pressure being generated and cause damage to the eye. Accordingly, it is desirable that a volume of vitreous material be removed from the eye prior to injecting an equal volume of drugs into the eyeball.
Various instruments have been developed for this purpose, most of which have been relatively complicated requiring large amounts of supporting equipment. U.S. Pat. No. 6,059,792 describes a sutureless vitrectomy tool that can be used to perform a vitrectomy procedure including removing all of the vitreous material from an eye. However, this device requires an operating room environment and electrical connections to a hand held instrument that utilizes a linear motor to repetitively drive a cutting tool within a 23 gauge stainless steel needle for removing vitreous from the eye. U.S. Pat. Nos. 5,989,262 and 5,716,363 describe sutureless pars plana vitrectomy tools using electrically powered actuators.
The present invention comprises a unitary mechanical combination injector and vitrector in the form of a manually operable hand tool that can be used when it is only necessary to remove a small volume of vitreous material from the eye (“vitrectomy”) in order to provide room for injection of antibiotics or other drugs into the eye. For example, the hand tool may be used to inject an antibiotic into a patient's eye by first removing sufficient vitreous material to approximate the volume of antibiotic fluid so as to prevent an undesirable increase in intraocular pressure. Using the hand tool of the present invention, a drug may be injected into a patient's eyeball in a procedure that may be performed in a doctor's office rather than having to be in a sterile environment of an operating room. Further, the present invention may be designed as a disposable item that is used once and then discarded, thus preventing cross-contamination from multiple use between different patients.
All patents, patent applications, provisional applications, and publications referred to or cited herein, or from which a claim for benefit of priority has been made, are incorporated herein by reference in their entirety to the extent they are not inconsistent with the explicit teachings of this specification.
A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same become better understood by reference to the following detailed description when considered in light of the following drawings, wherein:
a and 4b show an alternate embodiment of the probe tip for the intrector in which the sharpened tip is retracted once the probe has been inserted into an eye;
a and 5b show one form for implementing the retractable probe tip; and
a and 6b show another implementation of the retractable probe tip.
While the present invention will be described with reference to the details of the embodiments of the invention shown in the drawing, these details are not intended to limit the scope of the invention.
Referring to the drawings in general and in particular to
At the inner end 28 of cavity 16 there is an orifice 30 that provides an opening into a second cavity 32. The orifice 30 is sealed by a plug 34 attached to a lever 36 via an elongate arm 37 that is held in an extended position by a spring 39. The arm 37 is captured at end 41 in a slot 43 formed in lever 36. The lever 36 is seated in a ball pivot 38 that allows the lever to be pivoted without disrupting the integrity of the cavity 32. The lever 36 has an outer arm 40 that is held in the position shown in
The lever 36 is essentially an L-shaped member in which the outer arm portion 40 is arranged at an obtuse angle with respect to the other arm portion 44. The plug 34 is attached to the arm portion 44 via arm 37. When the arm portion 40 is pressed down causing the lever 36 to pivot, the arm portion 44 moves in a clockwise direction thereby pulling the plug 34 out of the orifice 30 allowing transfer of material between cavity 32 and cavity 16.
Also coupled to the arm portion 44 via connecting rod 58 is a second elongated member 46 (an inner cutter) that extends from an end of the arm portion 44 outward through a central bore of the needle portion 14. The needle portion 14 includes an outer needle 47 and the inner cutter 46. The needle 47, in addition to having a sharpened end 48 to facilitate insertion into the eye, is also provided with an aperture or cut out 50 into which vitreous material will flow when the needle portion 14 is inserted into an eye. As can be seen in
Turning back to
The tube 62 extends outward from the hand tool 10 and connects to a mechanical pressurization system comprising a conventional syringe 80 and a spring-loaded mechanism 82. The syringe 80 is typically supplied with a needle tip (not shown) that is then inserted into a drug container in a conventional manner and a measured amount of drug is drawn into the syringe. In this application, the needle is then removed from the end of the syringe and the tube 62 connected to the syringe in its place. The syringe is then coupled to the spring actuator 82 by simply depressing the spring and inserting the upper part of the syringe into the slot 84 so that the top end 86 of the syringe rests on an inner surface around the slot 84. The spring is then released to press against the plunger 88 of the syringe. The spring 90 pressing against the plunger 18 maintains a fixed pressure of fluid in the tubing 62. As would be recognized, the syringe would be actuated initially to force fluid from the syringe through the tubing 62 until some amount of fluid is released at the end of the tubing at the sharpened end 48 of the needle 14. The lever 72 would then be released to clamp the tubing before inserting the needle 14 into an eye of a patient.
The system of
A connecting rod 100 extends through housing 90 and connects at one end to about a center point of membrane 98. An opposite end of rod 100 is coupled to lever 36 such that pressing and releasing of lever arm 40 causes a reciprocating motion of rod 100 resulting in movement of membrane 98. As membrane 98 is pulled away from end wall 96, the fluid volume defined within the cavity 94 is increased. A one-way valve 102 allows fluid, air or liquid, to be drawn into cavity 94 via tube 92 as the membrane is pulled forward. When the lever 36 is released, the membrane moves toward rear wall 96 thereby decreasing the volume of cavity 94. A second one-way valve 104 provides a path for fluid to exit cavity 94 and be pushed into the large cavity 106 defined within housing 90. While the tube 92 is shown exiting the cavity 106 before being coupled to the cavity 94, it will be appreciated that different connections could be made to achieve the same result.
a and 4b illustrate a variation of the sharp tip configuration described above and replaces the needle 14 with a probe 120 having an outer tube 124 and an inner tube/cutter 122. It can be realized in conjunction with or without the inner tube 46 used for transporting liquids and can be adapted to any commercially available vitreous cutter probe. The sharp end 48 of the needle 14 can be formed as a part of the telescopically retractable outer trocar tube 124 thereby providing the sharp cutter necessary to insert the probe into the vitreous cavity. Once the outer trocar tube 124 is retracted, the blunt tip 130 of the inner tube 122 of the cutter/probe allows safe operation in close proximity to the retina, without the risk of accidental injury due to the sharp tip.
The cutting edge 126 creates an approximately half circular incision. The gradual ramp 128 extending from the cutting edge ensures that no further cutting of the incision occurs while the tip is advanced through the incision. The blunt tip 130 of the vitreous cutter/probe 122 is positioned in such a way relative to the outer trocar tube 124, that its distal end is protruding from the proximal edge 132 of the ramp. This ensures that the resulting tissue flap is displaced, rather than cut off by the proximal edge of the ramp. The combined length of the cutting edge and ramp of the trocar tube is approximately 1.5 to 3 mm.
a and 5b show one embodiment of a retraction mechanism for the telescoping outer trocar tube 124 to selectively expose and conceal the sharpened tip 126 for incisions. The cross-sectional view of
b shows a locking lug 142 engaged in a housing cutout 144, which secures the trocar tube 124 in its extended position during insertion of the device into the eye. Depressing the button 138 frees the locking lug 142 and enables the trocar tube 124 to be retracted into the position shown in
a and 6b show another embodiment of the retraction mechanism of
The mechanism described in
Further embodiments of a locking feature include crush bumps or tangs located in the housing cutout, which can engage a stationary dowel. Tangs, barbs or crush bumps may also be used between the trocar hub and handpiece to temporarily secure the device in either end position.
It will be appreciated that the present invention provides an advantageous way of removing small samples of vitreous material from an eye in order to provide space in the eye for injection of antibiotics or other drugs. Further, the device described herein can be constructed as a disposable device and provided as a pre-package sterile system. Still further, the device does not require any electrical connections and therefore simplifies the use such that it could be employed in non-operating room environment.
This application is a continuation of and claims priority to pending U.S. patent application Ser. No. 12/472,549, filed May 27, 2009, which is a continuation-in-part of and claims priority to U.S. patent application Ser. No. 11/463,465, filed Aug. 9, 2006, now U.S. Pat. No. 7,549,972, which claims priority from U.S. provisional application Ser. No. 61/101,454, filed Sep. 30, 2008, the disclosures of which are all incorporated herein by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
61101454 | Sep 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12472549 | May 2009 | US |
Child | 13542817 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11463465 | Aug 2006 | US |
Child | 12472549 | US |